UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
general & internal medicine (6) 6
life sciences & biomedicine (6) 6
medicine, general & internal (6) 6
obesity (6) 6
science & technology (6) 6
abridged index medicus (5) 5
humans (5) 5
weight loss (5) 5
clinical medicine (4) 4
diabetes (4) 4
double-blind method (4) 4
female (4) 4
internal medicine (4) 4
male (4) 4
obesity - drug therapy (4) 4
weight control (4) 4
anti-obesity agents - therapeutic use (3) 3
clinical trials (3) 3
drug therapy (3) 3
evaluation (3) 3
studies (3) 3
weight loss - drug effects (3) 3
adult (2) 2
anti-obesity agents (2) 2
anti-obesity agents - adverse effects (2) 2
blood pressure (2) 2
body mass index (2) 2
caloric restriction (2) 2
complications and side effects (2) 2
dosage and administration (2) 2
further section (2) 2
gastrointestinal surgery (2) 2
glucagon-like peptide 1 - analogs & derivatives (2) 2
glucagon-like peptide 1 - pharmacology (2) 2
human medicine (2) 2
injections, subcutaneous (2) 2
logistic models (2) 2
middle aged (2) 2
obesity - complications (2) 2
obesity - diet therapy (2) 2
obesity - epidemiology (2) 2
prediabetic state (2) 2
prediabetic state - complications (2) 2
prediabetic state - prevention & control (2) 2
research (2) 2
risk factors (2) 2
safety (2) 2
treatment outcome (2) 2
adolescent (1) 1
aged (1) 1
alzheimers disease (1) 1
analysis (1) 1
analysis of variance (1) 1
antidepressants (1) 1
anxiety disorders - chemically induced (1) 1
appetite depressants (1) 1
atkins diet (1) 1
autoimmune diseases (1) 1
back pain (1) 1
bicyclo compounds, heterocyclic (1) 1
biomedical research (1) 1
blood glucose - drug effects (1) 1
blood glucose - metabolism (1) 1
body composition (1) 1
body composition - drug effects (1) 1
body weight - drug effects (1) 1
body weight loss (1) 1
bridged bicyclo compounds, heterocyclic - adverse effects (1) 1
bridged bicyclo compounds, heterocyclic - therapeutic use (1) 1
carbohydrates (1) 1
cardiovascular disease (1) 1
cholesterol, hdl (1) 1
classification (1) 1
denmark (1) 1
depression - chemically induced (1) 1
developing countries--ldcs (1) 1
diabetes mellitus (1) 1
diabetes mellitus, type 2 - diagnosis (1) 1
diabetes mellitus, type 2 - drug therapy (1) 1
diabetes therapy (1) 1
diagnosis (1) 1
diet (1) 1
diet, reducing - adverse effects (1) 1
dietary carbohydrates - administration & dosage (1) 1
dietary fats - administration & dosage (1) 1
dose-response relationship, drug (1) 1
drug approval (1) 1
energy metabolism (1) 1
europe (1) 1
europe - epidemiology (1) 1
evidence-based medicine (1) 1
exercise (1) 1
food and nutrition (1) 1
gallbladder diseases (1) 1
glucagon-like peptide 1 (1) 1
glucagon-like peptide 1 - therapeutic use (1) 1
glucagon-like peptide-1 receptor - administration & dosage (1) 1
glucagon-like peptide-1 receptor - agonists (1) 1
glucose (1) 1
glucose metabolism (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2009, Volume 374, Issue 9701, pp. 1606 - 1616
Journal Article
by le Roux, Carel W and Astrup, Arne and Fujioka, Ken and Greenway, Frank and Lau, David C W and Van Gaal, Luc and Ortiz, Rafael Violante and Wilding, John P H and Skjøth, Trine V and Manning, Linda Shapiro and Pi-Sunyer, Xavier and Hamann, Andreas and Barakat, Alain and Blüher, Matthias and Linn, Thomas and Mölle, Andrea and Segner, Alexander and Stübler, Petra and Tosch-Sisting, Regina and Pacini, Furio and Santini, Ferruccio and Marchesini, Giulio and Rotella, Carlo Maria and Invitti, Cecilia and Vettor, Roberto and Buscemi, Silvio and Raya, Pedro Mezquita and Freijoo, Felipe Casanueva and de Barbará, Ramón Gomis and Carraro, Raffaele and Bobillo, Enrique Romero and de la Cuesta, Carmen and Farsang, Csaba and Csaszar, Albert and Zahorska-Markiewicz, Barbara and Pupek-Musialik, Danuta and Franek, Edward and Ostrowska, Lucyna and Olszanecka-Glinianowicz, Magdalena and Lalic, Nebojsa and Micic, Dragan and Ludvik, Bernhard and Paulweber, Bernhard and Prager, Rudolf and Scheen, André and Astrup, Arne Vernon and Hermansen, Kjeld and Madsbad, Sten and Rissanen, Aila and Nieminen, Sakari and Savolainen, Markku and Krempf, Michel and Romon, Monique and Laville, Martine and Marre, Michel and Mira, Reginald and Finucane, Francis and Veenendaal, Aletha and van Berkum, Frank and Johannsson-Vidarsdóttir, Solrun and Van de Walle, Vivienne and Meesters, Eelco and Hjelmesæth, Jøran and Klemsdal, Tor Ole and Kulseng, Bård and Bach-Kliegel, Birgit and Laederach, Kurt and Villiger, Lukas and Golay, Alain and Bilz, Stefan and Sathyapalan, Thozhukat and Bain, Stephen and Kumar, Sudesh and Le Roux, Carel Wynard and Lean, Michael E.J and McGowan, Barbara and Rehman, Tariq and Wilding, John and Wittert, Gary and Caterson, Ian and Proietto, Joeseph and Prins, John and Neto, Bruno Geloneze and Gross, Jorge Luiz and Chacra, Antonio Roberto and Halpern, Alfredo and de Almeida Suplicy, Henrique and Chow, Francis Chun Chung and Thacker, Hemant P and Chadha, Manoj and Chandalia, Hemaraj and Unnikrishnan, Ambika and Kalra, Sanjay and Deshpande, Neeta and Shunmugavelu, Minakshi and Deshmukh, Vaishali Chetan and Maislos, Maximo and Lieberman, Gabriella Segal and Shimon, Ilan and Stern, Naftali and ... and SCALE Obesity Prediabetes NN8022-1839 Study Group and SCALE Obesity & Prediabet NN8022
The Lancet (British edition), ISSN 0140-6736, 04/2017, Volume 389, Issue 10077, pp. 1399 - 1409
Summary Background Liraglutide 3·0 mg was shown to reduce bodyweight and improve glucose metabolism after the 56-week period of this trial, one of four trials... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Obesity - drug therapy | Glucagon-Like Peptide-1 Receptor - administration & dosage | Humans | Middle Aged | Body Weight - drug effects | Male | Weight Loss - drug effects | Liraglutide - pharmacology | Injections, Subcutaneous | Adult | Female | Placebos - administration & dosage | Body Mass Index | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Risk Reduction Behavior | Glucagon-Like Peptide 1 - analogs & derivatives | Obesity - complications | Glucagon-Like Peptide 1 - pharmacology | Prediabetic State - prevention & control | Treatment Outcome | Prediabetic State - complications | Blood Glucose - drug effects | Prediabetic State - diagnosis | Diabetes Mellitus, Type 2 - diagnosis | Liraglutide - adverse effects | Obesity - epidemiology | Placebos - pharmacology | Incretins - therapeutic use | Liraglutide - administration & dosage | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide-1 Receptor - agonists | Type 2 diabetes | Clinical trials | Glucose metabolism | Risk factors | Prediabetic state | Diabetes therapy | Exercise | Obesity | Evaluation | Diabetes mellitus | Health risks | Weight loss | Glucose | Evidence-based medicine | Studies | Weight control | Randomization | Immunology | Classification | Weight reduction | Gastrointestinal surgery | Diabetes | Clinical medicine | Diagnosis | Autoimmune diseases | Risk management | Back pain | Physical activity | Gallbladder diseases | Body weight loss | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Hypertension | Risk reduction | Metabolism | Investigations | Nutrition research | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9653, pp. 1906 - 1913
Journal Article
The Lancet (British edition), ISSN 0140-6736, 12/2000, Volume 356, Issue 9248, pp. 2119 - 2125
Sibutramine is a tertiary amine that has been shown to induce dose-dependent weight loss and to enhance the effects of a low-calorie diet for up to a year. We... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Evaluation | Triglycerides | Sibutramine | Cholesterol, HDL | Weight loss | Clinical trials | Obesity | Prescription drugs | Antidepressants | Neurons
Journal Article
Obesity facts, ISSN 1662-4025, 10/2010, Volume 3, Issue 5, pp. 335 - 335
Journal Article
Obesity facts, ISSN 1662-4025, 07/2008, Volume 1, Issue 3, pp. 165 - 165
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.